Literature DB >> 9777676

Human oligodendroglial development: relationship to periventricular leukomalacia.

H C Kinney1, S A Back.   

Abstract

Periventricular leukomalacia in the premature infant is a lesion of cerebral white matter with its greatest period of risk when white matter is immature, that is, when oligodendrocyte precursors are proliferating and differentiating, and before myelin sheaths are actively synthesized. Although the pathogenesis of perinatal cerebral white matter damage involves multiple factors, the correlation of the timing of the lesion with dominance of oligodendrocyte precursors in cerebral white matter suggests that intrinsic factors related to oligodendrocyte precursors are critical. Ischemia and infection have both been implicated as causes of perinatal white matter damage. Major mechanisms underlying oligodendrocyte injury in ischemia include glutamate toxicity, free-radical injury, and cytokine damage mediated by macrophages accompanying ischemia-induced inflammation. Factors related to a vulnerability of immature oligodendrocytes to ischemia potentially include a developmental lack of antioxidant enzymes to mediate oxidative stress. Cytokine-mediated injury to oligodendrocytes is also potentially important. A complete understanding of the role of immature white matter in the pathogenesis of periventricular leukomalacia is essential for developing strategies to prevent it.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9777676     DOI: 10.1016/s1071-9091(98)80033-8

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  48 in total

1.  Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injury.

Authors:  Art Riddle; Jennifer Maire; Xi Gong; Kevin X Chen; Christopher D Kroenke; A Roger Hohimer; Stephen A Back
Journal:  Stroke       Date:  2011-11-10       Impact factor: 7.914

Review 2.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

Review 3.  Preclinical Models of Encephalopathy of Prematurity.

Authors:  Lauren L Jantzie; Shenandoah Robinson
Journal:  Dev Neurosci       Date:  2015-02-18       Impact factor: 2.984

4.  Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants.

Authors:  Joshua R Buser; Jennifer Maire; Art Riddle; Xi Gong; Thuan Nguyen; Kerst Nelson; Ning Ling Luo; Jennifer Ren; Jaime Struve; Larry S Sherman; Steven P Miller; Vann Chau; Glenda Hendson; Praveen Ballabh; Marjorie R Grafe; Stephen A Back
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

Review 5.  Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances.

Authors:  Joseph J Volpe
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

Review 6.  Neurobiology of injury to the developing brain.

Authors:  Wenbin Deng
Journal:  Nat Rev Neurol       Date:  2010-05-18       Impact factor: 42.937

7.  Axon-glia synapses are highly vulnerable to white matter injury in the developing brain.

Authors:  Yan Shen; Xiao-Bo Liu; David E Pleasure; Wenbin Deng
Journal:  J Neurosci Res       Date:  2011-08-02       Impact factor: 4.164

8.  Vulnerability of premyelinating oligodendrocytes to white-matter damage in neonatal brain injury.

Authors:  Xiao-Bo Liu; Yan Shen; Jennifer M Plane; Wenbin Deng
Journal:  Neurosci Bull       Date:  2013-02-28       Impact factor: 5.203

Review 9.  Fetal inflammatory response and brain injury in the preterm newborn.

Authors:  Shadi Malaeb; Olaf Dammann
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

10.  Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures.

Authors:  Manjeet K Paintlia; Ajaib S Paintlia; Mushfiquddin Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurochem       Date:  2008-01-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.